Jian-Ming Xu

Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition)

Jian Zhou, Hui‐Chuan Sun, Zheng Wang et al. · Liver Cancer · 2018 · 688 citations · Full text

Medicine, Oncology, Radiology +17

Anti-PD-1 Antibody SHR-1210 Combined with Apatinib for Advanced Hepatocellular Carcinoma, Gastric, or Esophagogastric Junction Cancer: An Open-label, Dose Escalation and Expansion Study

Jian-Ming Xu, Yun Zhang, Ru Jia et al. · Clinical Cancer Research · 2018 · 533 citations

Pharmacy, Oncology, Pharmacology +16

Efficacy and safety of bevacizumab plus chemotherapy in Chinese patients with metastatic colorectal cancer: a randomized phase III ARTIST trial

Zhong-Zhen Guan, Jian-Ming Xu, Rong-Cheng Luo et al. · Chinese Journal of Cancer · 2011 · 119 citations · Full text

Medicine, Oncology, Pharmacology +9

<i>PIK3CA</i> Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer

Jian-Ming Xu, Yan Wang, Youliang Wang et al. · Clinical Cancer Research · 2017 · 78 citations · Full text

Medicine, Oncology, Pharmacology +17

Surufatinib in Advanced Well-Differentiated Neuroendocrine Tumors: A Multicenter, Single-Arm, Open-Label, Phase Ib/II Trial

Jian-Ming Xu, Jie Li, Chunmei Bai et al. · Clinical Cancer Research · 2019 · 76 citations

Medicine, Oncology, Pharmacology +17